In this episode, Andrew Huberman explains the neuroscience behind Obsessive Compulsive Disorder (OCD), focusing on the corticostriatal thalamic brain loop that drives the cycle of intrusive obsessions and compulsive behaviors. He highlights that engaging in compulsions paradoxically strengthens obsessions, and reviews the most effective treatments, including Exposure and Response Prevention (ERP) therapy, which significantly outperforms SSRIs. The episode also covers genetic factors, the Yale Brown scale for diagnosis, and why supplements or cannabis are not effective for OCD.
Summarized by Podsumo
OCD affects 2.5-4% of the population and is the 7th most debilitating illness globally, more debilitating than many physical diseases.
The core mechanism is a dysfunctional corticostriatal thalamic brain loop; engaging in compulsions actually strengthens the obsessions they aim to relieve.
Exposure and Response Prevention (ERP) therapy, which teaches anxiety tolerance by preventing compulsive behaviors, is significantly more effective than SSRIs alone.
Despite being used, controlled studies show cannabis (THC/CBD) and myo-inositol have little to no acute impact on OCD symptoms.
Mindfulness meditation may help indirectly by improving focus on CBT homework, but does not directly relieve OCD symptoms.
"The obsessions are intrusive. People don't want to have them. They don't enjoy having them. They just seem to pop into people's minds recurrently."
"Every time that one engages in the compulsion related to the obsession, the obsession simply becomes stronger."
"What they're trying to get the patient to do is to really feel the anxiety at its maximum, but then do the exact opposite of whatever the normal compulsion is."